Brain somatostatin depletion by cysteamine attenuates the penile erection induced by serotonergic and dopaminergic, but not by cholinergic, activation In rats

Brain Research

Volumn 729, Issue 1, 1996, Pages 132-136

  Matsuoka, Nobuya ^a   Maeda, Noriaki ^a   Yamazaki, Mayako ^a   Yamaguchi, Isamu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Cholinergic; Cysteamine; Dopaminergic; Penile erection; Serotonergic; Somatostatin

Indexed keywords

APOMORPHINE; FENFLURAMINE; MERCAPTAMINE; SOMATOSTATIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PENIS ERECTION; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030570811     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00560-4     Document Type: Article

References (28)

1. [1] Baraldi, M., Benassi-Benelli, A. and Lolli, M., Penile erections in rats after fenfluramine administration, Riv. Farmacol. Ther., 8 (1977) 375-379.
2. [2] Baraldi, M. and Bertolini, A., Penile erections induced by amantadine in male rats, Life Sci., 14 (1974) 1231-1235.
3. [3] Benassi-Benelli, A., Ferrani, F. and Pelegrini-Quarantotti, B., Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats, Arch. Int. Pharmacodyn. Ther., 241 (1979) 128-134.
4. [4] Bennett, G.W., Edwardson, J.A., Marcano de Cotte, D., Berelowitz, M., Pimstone, B.L. and Kronheim, S., Release of somatostatin from rat brain synaptosomes, J. Neurochem., 32 (1979) 1127-1130.
5. 1C-receptors in drug-induced penile erections in rats, Psychopharmacology, 101 (1990) 57-61.
6. [6] Brown, M., Fisher, L., Mason, R.T., Rivier, J. and Vale, W., Neurobiological actions of cysteamine, Fed. Proc., 44 (1985) 2556-2560.
7. [7] Chattha, G.K. and Beal, M.F., Effect of cysteamine on somatostatin and neuropeptide Y in rat striatum and cortical synaptosomes, Brain Res., 401 (1987) 359-364.
8. [8] Dodd, J. and Kelly, J.S., Is somatostatin an excitatory transmitter in the hippocampus? Nature, 273 (1978) 674-675.
9. [9] Epelbaum, J., Somatostatin in the central nervous system: physiology and pathological modifications, Prog. Neurobiol., 27 (1986) 63-100.
10. [10] Fonnum, F., A rapid radiochemical method for the determination of choline acetyltransferase, J. Neurochem., 24 (1975) 407-409.
11. [11] Gower, A.J., Berendsen, H.H.G., Proncen, M.M. and Broekkamp, C.L.E., The yawning-penile erection syndrome as a model for putative dopamine autoreceptor activity, Eur. J. Pharmacol., 103 (1984) 81-89.
12. [12] Johansson, O., Hökfelt, T. and Elde, R.P., Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat, Neuroscience, 13 (1984) 265-339.
13. [13] Lowry, O.H., Rosenberg, N.J., Fair, A.L. and Randall, R.J., Protein measurement with Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
14. [14] MacLean, P.D., Brain mechanisms of primal sexual functions and related behavior. In M. Sandler and G.L. Gessa (Eds.), Sexual Behavior: Pharmacology and Biochemistry, Raven Press, New York, 1975, pp. 1-11.
15. [15] Maeda, N., Matsuoka, N. and Yamaguchi, I., Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants, Brain Res., 537 (1990) 163-168.
16. [16] Maeda, N., Matsuoka, N. and Yamaguchi, I., Role of dopaminergic, serotonergic and cholinergic link in the expression of penile erection in rats, Jpn. J. Pharmacol., 66 (1994) 59-66.
17. [17] Maeda, N., Matsuoka, N. and Yamaguchi, I., Possible involvement of the septo-hippocampal cholinergic and raphe-hippocampal serotonergic activations in the penile erection induced by fenfluramine in rats, Brain Res., 652 (1994) 181-189.
18. [18] Matsuoka, N., Kaneko, S. and Satoh, M., Somatostatin augments long-term potentiation of the mossy fiber-CA3 system in guinea-pig hippocampal slices, Brain Res., 553 (1991) 188-194.
19. [19] Matsuoka, N., Maeda, N., Yamaguchi, I. and Satoh, M., Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task, Brain Res., 642 (1994) 11-19.
20. [20] Matsuoka, N., Yamazaki, M. and Yamaguchi, I., Changes in brain somatostatin in memory deficient rats: comparison with cholinergic markers, Neuroscience, 66 (1995) 617-626.
21. [21] Mesulam, M.-M., Mufson, E.J., Wainer, B.H. and Levey, A.I., Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6), Neuroscience, 10 (1983) 1185-1201.
22. [22] Moore, R.Y., Halaris, A.E. and Jones, B.E., Serotonin neurons of the midbrain raphe: ascending projections, J. Comp. Neurol., 180 (1978) 417-438.
23. [23] Nilsson, O.G., Leanza, G. and Björklund, A., Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo microdialysis, Brain Res., 584 (1992) 132-140.
24. [24] Palkovits, M., Brownstein, M.J., Eiden, L.E., Beinfeld, M.C., Arimura, A. and Szabo, S., Selective depletion of somatostatin in rat brain by cysteamine, Brain Res., 240 (1982) 178-180.
25. [25] Robinson, S.E., Malthe-Sorenssen, D. and Wood, P.L., Dopaminergic control of the septo-hippocampal cholinergic pathway, J. Pharmacol. Exp. Ther., 208 (1979) 476-479.
26. [26] Sagar, S.M., Landry, D., Millard, W.J., Badger, T.M., Arnold, M.A. and Martin, J.B., Depletion of somatostatin-like immunoreactivity in the rat central nervous system by cysteamine, J. Neurosci., 2 (1982) 225-231.
27. [27] Szabo, S. and Reichlin, S., Somatostatin in rat tissue is depleted by cysteamine administration, Endocrinology, 109 (1981) 2255-2257.
28. [28] Terry, L.C. and Craig, R., Cysteamine effects on monoamines, dopamine-beta-hydroxylase and the hypothalamic-pituitary axis, Neuroendocrinology, 41 (1985) 467-475.